Imaging biomarkers in DME and RVO: from disease development to treatment

This advanced course explores the role of imaging biomarkers in the diagnosis, monitoring, and treatment of diabetic macular oedema and retinal vein occlusion. Through high-resolution OCT, OCT-angiography, multimodal imaging, and artificial intelligence applications, participants will gain a deeper understanding of disease mechanisms and learn how to translate imaging findings into personalized, evidence-based therapeutic decisions.

ESASO Scientific Director: Mario Romano
Course Scientific Coordinator: José Medel

An application has been made to the EACCME® for CME accreditation of this event

Teaching language: English 🇬🇧

Next Course in 2027 🎯

Only 20 seats available 🔥

⭐⭐⭐⭐⭐ More than 1700 students

🎗️ This course awards you with 1/5 MDHO Points

What you'll learn

✔️

How to identify clinically relevant OCT and OCT-A biomarkers in DME and RVO

✔️

How retinal ischemia and structural changes influence disease progression

✔️

How multimodal imaging improves diagnostic accuracy and treatment planning

✔️

How imaging biomarkers guide therapeutic choices, including treatment switching

Skills you'll acquire

Advanced OCT and OCT-A interpretation

Imaging-based clinical decision-making

Biomarker-driven treatment selection

Multimodal retinal imaging analysis

Early identification of disease progression

From

Free

Pay later with  

Take me to the registration form

Date: 13 May 2026
Venue: Online on eLOS
Level: Advanced

This course includes:

🧑🏻‍🏫2 educational hours
🧑🏻‍🏫 International, experienced Faculty
⬇️ Downloadable resources
🗨️ eLOS account
🦸🏻‍♂️ Assistance of Event Manager
🏅 Accreditation Certificate
📜 ESASO Certificate of Attendance
🇨🇭 Swiss-level organisation

Course sponsorIndependent support grant

Course Programme